Tag: Brain disease modalities and software Market

Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.

Brain Disease Device And Software Market Size, Value And Growth Trajectory Through 2030

The brain disease device and software market has seen considerable expansion in recent years. It is anticipated to grow from $15.59 billion in 2025 to $17.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. The historical increase in this market can be linked to factors such as the scarcity of effective brain disease diagnostic instruments, the increasing occurrence of neurological conditions, the improvement of hospital and clinic infrastructure, the initial embrace of telemedicine technologies, and a reliance on conventional brain imaging methods.

The brain disease device and software market is anticipated to experience substantial expansion over the upcoming years. By 2030, this market is projected to reach $25.21 billion, exhibiting a compound annual growth rate (CAGR) of 10.0%. This projected growth stems from several factors, including developments in wearable and AI-powered brain disease devices, increased capital allocation towards neurorehabilitation technologies, the proliferation of home care and remote patient monitoring options, escalating demand for software managing brain data, and intensified research into neuroinformatics and cognitive assessment tools. Key trends for the forecast period encompass a greater uptake of neurostimulation and brain monitoring devices, the incorporation of telemedicine and remote patient monitoring, an increase in cognitive assessment and neurofeedback software, an amplified emphasis on individualized treatments for brain disorders, and the broadening of neuroimaging and data analytics capabilities.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=91767472&type=smp&name=Brain%20Disease%20Device%20And%20Software%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Brain Disease Device And Software Market Growth Catalysts And Demand Drivers

The projected expansion of the brain disease device and software market is linked to the increasing occurrence of neurological disorders. These medical conditions affect the brain, spinal cord, and nerves, leading to diverse symptoms such as cognitive, motor, and sensory impairments. The rising prevalence of neurological disorders is connected to the world’s aging population, as aging progressively impairs neuronal function, reduces brain plasticity, and elevates oxidative stress, which contributes to the development and advancement of these conditions. Brain disease devices and software assist in managing neurological disorders through early diagnosis and continuous monitoring. They also enable timely intervention via advanced AI and data analytics, thereby improving patient care and treatment outcomes. For instance, in July 2024, according to the National Health Service, a UK-based government agency, there were 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, an increase of 3,155 cases compared to May 31, 2024. This demonstrates how the increasing prevalence of neurological disorders is driving the growth of the brain disease device and software market.

Brain Disease Device And Software Market Segmentation And Category Overview

The brain disease device and software market covered in this report is segmented –

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

Brain Disease Device And Software Market Trends Shaping Long-Term Demand

Key companies within the brain disease device and software market are increasingly harnessing innovative technologies, such as artificial intelligence (AI)-driven brain imaging analytics, in order to improve the early and precise detection, tracking, and management of neurodegenerative conditions including Alzheimer’s disease and dementia. These AI-powered brain imaging analytics utilize advanced software platforms applying machine-learning models to MRI and other neuroimaging data. Their purpose is to pinpoint subtle microstructural alterations in brain tissue often missed by conventional volumetric imaging, leading to a much earlier and more sensitive diagnosis. An example is found in January 2025, when Oxford Brain Diagnostics Ltd., a UK-based medtech company, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance and then introduced CDM Insights. This cloud-native software solution is built upon their proprietary Cortical Disarray Measurement (CDM) technology. This tool processes routine 1.5 T and 3 T MRI scans to produce novel measures of cortical thickness and microstructural disarray within grey matter, thereby offering objective, quantifiable indicators of neurodegeneration. Following these regulatory approvals, the company began its commercial rollout across healthcare systems in the US and UK, assisting clinicians with early diagnosis, disease monitoring, and treatment stratification.

Brain Disease Device And Software Market Key Players Shaping Industry Direction

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI

View The Full Brain Disease Device And Software Market Report:

https://thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Sep_PR

Brain Disease Device And Software Market Regional Analysis: Which Geography Leads On Revenue?

North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Growth In Market Value Is Anticipated For The Brain Disease Device And Software Market Between 2026 And 2030?

The brain disease device and software market has witnessed rapid growth in recent years. It is forecast to increase from $15.59 billion in 2025 to $17.2 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.3%. This historical expansion can be attributed to several factors including the limited availability of brain disease diagnostic tools, the rising prevalence of neurological disorders, enhancements in hospital and clinic infrastructure, the early adoption of telemedicine solutions, and a reliance on traditional brain imaging techniques.

The brain disease device and software market is projected to experience swift expansion over the coming years. By 2030, its value is anticipated to reach $25.21 billion, exhibiting a compound annual growth rate (CAGR) of 10.0%. This anticipated growth during the forecast period stems from developments in wearable and AI-enabled devices for brain diseases, greater capital allocation to neurorehabilitation technologies, the spread of home care and distant monitoring options, an increasing need for software to manage brain data, and expanding research in neuroinformatics and cognitive evaluation methods. Significant trends expected in the forecast period involve the growing use of neurostimulation and brain monitoring devices, the incorporation of telemedicine alongside remote patient observation, the advancement of cognitive assessment and neurofeedback software, a heightened emphasis on individualized treatments for brain disorders, and the broadening of neuroimaging and data analytics solutions.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

Which Major Factors Are Contributing To The Development Of The Brain Disease Device And Software Market?

The rising occurrence of neurological conditions is anticipated to fuel the expansion of the brain disease device and software market in the future. These are health issues impacting the brain, spinal cord, and nerves, manifesting in various symptoms such as difficulties with cognition, movement, and sensation. The growing incidence of neurological disorders correlates with the world’s aging demographic, given that aging progressively diminishes neuronal function, decreases brain’s adaptability, and heightens oxidative stress, thereby facilitating the onset and advancement of these conditions. Brain disease devices and software assist in managing neurological disorders through facilitating prompt diagnosis and ongoing monitoring. Furthermore, they enable timely interventions utilizing sophisticated AI and data analytics, which enhances patient care and improves treatment results. To illustrate, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients had been diagnosed with dementia (a progressive brain disorder impacting memory, thought, and daily functions) by June 30, 2024. This represented an increase of 3,155 cases from May 31, 2024. Consequently, the expanding occurrence of neurological disorders is propelling the growth of the brain disease device and software market.

What Key Segment Areas Are Included In The Brain Disease Device And Software Market Assessment?

The brain disease device and software market covered in this report is segmented –

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

Which Trends Are Shaping The Brain Disease Device And Software Market Landscape?

Leading companies in the brain disease device and software market are increasingly focusing on utilizing innovative technologies, such as artificial intelligence (AI)-driven brain imaging analytics, to improve the early and accurate detection, monitoring, and management of neurodegenerative conditions like Alzheimer’s disease and dementia. AI-driven brain imaging analytics involves advanced software platforms that apply machine-learning models to MRI and other neuroimaging data, enabling the identification of subtle microstructural alterations in brain tissue that might be overlooked by conventional volumetric imaging, thereby allowing for earlier and more sensitive diagnosis. For instance, in January 2025, Oxford Brain Diagnostics Ltd., a UK-based medtech company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance and subsequently launched CDM Insights, a cloud-native software solution based on its proprietary Cortical Disarray Measurement (CDM) technology. This tool analyzes routine 1.5 T and 3 T MRI scans to generate novel measures of cortical thickness and microstructural disarray in grey matter, offering objective, quantifiable indicators of neurodegeneration. Following these regulatory approvals, the company initiated its commercial rollout across healthcare systems in the US and UK, supporting clinicians in early diagnosis, disease monitoring, and treatment stratification.

Who Are The Major Companies Operating In The Brain Disease Device And Software Market?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI

Access The Complete Brain Disease Device And Software Market Report:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Region Stands As The Largest Contributor To The Brain Disease Device And Software Market?

North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access a Customized Brain Disease Device And Software Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2026, By The Business Research Company

Building Insulation Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Technical Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Building Thermal Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-thermal-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Expected Market Size Of The Brain Disease Device And Software Market From 2026 To 2030?

The brain disease device and software market has experienced significant expansion recently. It is projected to increase from $15.59 billion in 2025 to $17.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. The historical growth in this sector can be attributed to a range of factors, including the scarcity of effective brain disease diagnostic tools, a rising incidence of neurological disorders, the development of hospital and clinic infrastructure, the initial implementation of telemedicine solutions, and a reliance on conventional brain imaging techniques.

The brain disease device and software market size is forecast to experience substantial expansion in the coming years. It is projected to reach $25.21 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 10.0%. This projected growth is driven by advancements in wearable and AI-enabled brain disease devices, heightened investment in neurorehabilitation technologies, the increasing availability of home care and remote monitoring solutions, a rising need for brain data management software, and expanding research in neuroinformatics and cognitive assessment technologies. Prominent trends expected during this period involve the growing adoption of neurostimulation and brain monitoring devices, the integration of telemedicine and remote patient monitoring, the development of cognitive assessment and neurofeedback software, an increasing focus on personalized brain disorder treatment, and the expansion of neuroimaging and data analytics solutions.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

What Key Drivers Are Influencing The Growth Of The Brain Disease Device And Software Market?

The rising occurrence of neurological conditions is anticipated to stimulate the expansion of the brain disease device and software market in the future. Neurological disorders are health issues impacting the brain, spinal cord, and nerves, resulting in various signs such as cognitive, motor, and sensory difficulties. The growing frequency of these disorders is attributed to the aging global populace, since aging progressively hinders neuronal function, diminishes brain plasticity, and heightens oxidative stress, thereby fostering the onset and advancement of these conditions. Brain disease devices and software assist in managing neurological disorders by allowing for early detection and ongoing observation. They facilitate prompt action via advanced AI and data analytics, thereby enhancing patient care and improving treatment results. For instance, in July 2024, the National Health Service, a UK-based government agency, reported 487,432 patients diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, which represented an increase of 3,155 cases compared to May 31, 2024. Consequently, the increasing prevalence of neurological disorders is fueling the development of the brain disease device and software market.

Which Segments Are Included In The Analysis Of The Brain Disease Device And Software Market?

The brain disease device and software market covered in this report is segmented –

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

Which Trends Are Impacting The Growth Of The Brain Disease Device And Software Market?

Major companies within the brain disease device and software market are increasingly adopting advanced technologies, such as artificial intelligence (AI)-driven brain imaging analytics, to enhance the timely and precise identification, observation, and treatment of neurodegenerative disorders including Alzheimer’s disease and dementia. These AI-powered brain imaging analytics utilize sophisticated software platforms that apply machine-learning models to MRI and other neuroimaging data. This allows for the detection of subtle microstructural changes in brain tissue that traditional volumetric imaging might not discern, thereby facilitating earlier and more sensitive diagnoses. For example, in January 2025, Oxford Brain Diagnostics Ltd., a medtech company based in the UK, obtained U.S. Food and Drug Administration (FDA) 510(k) clearance before introducing CDM Insights. This cloud-native software solution, built on its exclusive Cortical Disarray Measurement (CDM) technology, processes standard 1.5 T and 3 T MRI scans to produce new measurements of cortical thickness and microstructural disarray within grey matter, offering objective, measurable indicators of neurodegeneration. Subsequent to these regulatory approvals, the company initiated its commercial deployment across healthcare systems in the US and UK, assisting clinicians with early diagnosis, disease monitoring, and guiding treatment strategies.

Which Key Industry Participants Are Active In The Brain Disease Device And Software Market?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI

Read the full brain disease device and software market report here:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Region Is Expected To Register The Fastest Growth In The Brain Disease Device And Software Market?

North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Brain Disease Device And Software Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2026, By The Business Research Company

Building Insulation Materials Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Technical Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Building Thermal Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-thermal-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the radiation dose optimisation software market from 2026–2035 with trusted insights from The Business Research Company

What is the estimated market size of the Brain Disease Device And Software Market by the end of 2030?

The brain disease device and software market size has experienced rapid expansion in recent years. This market is anticipated to increase from $15.59 billion in 2025 to $17.2 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.3%. Historically, this growth can be attributed to the limited availability of brain disease diagnostic tools, the growing prevalence of neurological disorders, rising hospital and clinic infrastructure, early-stage adoption of telemedicine solutions, and a dependence on traditional brain imaging techniques.

The brain disease device and software market is projected for significant expansion in the coming years. By 2030, this market is anticipated to reach a valuation of $25.21 billion, demonstrating a compound annual growth rate (CAGR) of 10.0%. Key drivers for this growth throughout the forecast period include innovations in wearable and AI-powered brain disease devices, increased funding for neurorehabilitation technologies, the broadening of home care and remote patient monitoring options, a growing need for brain data management software, and expanded research in neuroinformatics and cognitive evaluation technologies. Significant trends expected during this time frame involve the increased use of neurostimulation and brain monitoring tools, the incorporation of telemedicine and remote patient monitoring, an uptick in cognitive assessment and neurofeedback software development, a heightened emphasis on individualized treatments for brain disorders, and the widespread application of neuroimaging and data analytics solutions.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

What Drivers Are Shaping Future Opportunities In The Brain Disease Device And Software Market?

The expanding occurrence of neurological conditions is projected to boost the brain disease device and software market in the future. Neurological disorders are health issues impacting the brain, spinal cord, and nerves, leading to diverse symptoms like cognitive, motor, and sensory difficulties. The rising incidence of these disorders is associated with the world’s aging population, as aging progressively impairs nerve function, decreases brain adaptability, and heightens oxidative stress, facilitating the onset and progression of these conditions. Brain disease devices and software aid in managing neurological disorders through facilitating early detection and ongoing tracking. They enable prompt actions via sophisticated AI and data analytics, thereby enhancing patient well-being and treatment efficacy. For example, in July 2024, as reported by the National Health Service, a UK-based government agency, 487,432 patients had been diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, marking an increase of 3,155 cases from May 31, 2024. Consequently, the growing prevalence of neurological disorders is stimulating the expansion of the brain disease device and software market.

Which Segment Groups Are Influencing The Brain Disease Device And Software Market?

The brain disease device and software market covered in this report is segmented –

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

How Are New Market Trends Shaping The Landscape Of The Brain Disease Device And Software Market?

Leading companies in the brain disease device and software market are prioritizing the adoption of innovative technologies, such as artificial intelligence (AI)-driven brain imaging analytics, to enhance the early and accurate detection, monitoring, and management of neurodegenerative conditions like Alzheimer’s disease and dementia. Artificial intelligence-driven brain imaging analytics incorporates advanced software platforms that apply machine-learning models to MRI and other neuroimaging data. This allows for the identification of subtle microstructural alterations in brain tissue that conventional volumetric imaging might overlook, thereby enabling an earlier and more sensitive diagnosis. For instance, in January 2025, Oxford Brain Diagnostics Ltd., a UK-based medtech company, secured U.S. Food and Drug Administration (FDA) 510(k) clearance and then launched CDM Insights, a cloud-native software solution built on its proprietary Cortical Disarray Measurement (CDM) technology. This tool processes routine 1.5 T and 3 T MRI scans to produce novel measures of cortical thickness and microstructural disarray in grey matter, offering objective, quantifiable indicators of neurodegeneration. Following these regulatory approvals, the company commenced its commercial rollout across healthcare systems in the US and UK, assisting clinicians with early diagnosis, disease monitoring, and treatment stratification.

Who Are The Major Companies Operating In The Brain Disease Device And Software Market?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Brain Disease Device And Software Market?

North America was the largest region in the brain disease device and software market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Brain Disease Device And Software Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2026, By The Business Research Company

Building Insulation Materials Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Technical Insulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Building Thermal Insulation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/building-thermal-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Uncover key drivers, emerging technologies, and competitive movements shaping the brain disease device and software market from 2025–2034 with trusted insights from The Business Research Company

How Is The Brain Disease Device And Software Market Expected To Grow In Terms Of Size?

The brain disease device and software market has witnessed substantial expansion in recent years. It is anticipated to increase from $14.11 billion in 2024 to $15.59 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.5%. This historical growth can be ascribed to several factors, including the rising occurrence of neurological disorders, enhanced awareness concerning early diagnosis and treatment of brain conditions, an increasing demand for non-invasive diagnostic instruments, expanding government investments in healthcare infrastructure, and a growing patient inclination towards home-based neurological monitoring.

The brain disease device and software market is anticipated to experience substantial growth over the next few years. This market is projected to expand to $22.94 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is driven by increasing demand for personalized brain disease management solutions, a wider embrace of cloud-based platforms for analyzing brain health data, a heightened focus on remote patient monitoring and telehealth services, the growing presence of smartphones and mobile applications in healthcare, and the rising adoption of digital therapeutics for cognitive disorders. Significant trends expected in this period include the integration of wearable brain monitoring devices, advancements in neurostimulation devices, the development of closed-loop neurostimulation systems, and ongoing improvements in imaging technologies and neuroimaging techniques.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

What Are The Primary Factors Supporting The Brain Disease Device And Software Market Expansion?

The rising occurrence of neurological conditions is projected to drive the expansion of the brain disease device and software market in the future. These disorders are health issues impacting the brain, spinal cord, and nerves, resulting in various symptoms such as cognitive, motor, and sensory difficulties. The growing incidence of neurological disorders is associated with the world’s aging demographic, since aging progressively diminishes neuronal function, decreases brain plasticity, and heightens oxidative stress, thereby fostering the onset and advancement of these conditions. Brain disease devices and software assist in managing neurological disorders through facilitating early detection and ongoing observation. These tools enable prompt intervention via sophisticated AI and data analytics, enhancing patient care and therapeutic results. As an illustration, the National Health Service, a UK government body, reported in July 2024 that 487,432 patients had been diagnosed with dementia (a degenerative brain condition impacting memory, thought, and daily functions) by June 30, 2024, marking an increase of 3,155 cases from May 31, 2024. Consequently, the expanding occurrence of neurological disorders is fueling the growth of the brain disease device and software market.

Which Segmentation Categories Are Highlighted In The Brain Disease Device And Software Market Analysis?

The brain disease device and software market covered in this report is segmented

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

Which Market Trends Are Expected To Define The Future Of The Brain Disease Device And Software Market?

Leading companies in the brain disease device and software market are concentrating on developing novel solutions, such as digital healthcare innovations, to improve early diagnosis and management of neurological disorders. Digital healthcare solutions encompass technology-enabled tools and platforms that utilize software, connected devices, and data analytics to support the prevention, diagnosis, monitoring, and treatment of various health conditions, including neurological ailments. For instance, in July 2022, Linus Health Inc., a US-based digital health company, introduced an iPad-powered brain health platform intended for the early detection of Alzheimer’s disease and other dementias in primary care settings. This platform employs digital cognitive assessments and AI-driven analytics to offer clinicians practical insights, facilitating quicker interventions and customized care plans. Its goal is to enhance accessibility and efficiency in identifying cognitive decline at its nascent stages by integrating smoothly into routine primary care visits. This development underscores the increasing focus on digital instruments for transforming neurological care, providing scalable and precise methods for identifying and overseeing brain health conditions.

Which Organizations Are At The Forefront Of The Brain Disease Device And Software Market?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Geographic Regions Are Creating Strong Demand In The Brain Disease Device And Software Market?

North America was the largest region in the brain disease device and software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2025, By The Business Research Company

Industrial Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/industrial-insulation-global-market-report

Technical Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Building Thermal Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/building-thermal-insulation-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

What Are The Growth Projections For The Brain Disease Device And Software Market Size During 2025–2029?

The brain disease device and software market has witnessed rapid growth in recent years. It is anticipated to expand from $14.11 billion in 2024 to $15.59 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.5%. This historical growth can be attributed to factors such as the increasing occurrence of neurological disorders, greater understanding of the benefits of early diagnosis and treatment for brain diseases, a rising demand for non-invasive diagnostic tools, expanding government investments in healthcare infrastructure, and a growing patient preference for home-based neurological monitoring.

The brain disease device and software market is poised for significant expansion in the coming years. Projections indicate it will reach $22.94 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 10.1%. This expansion during the forecast period is primarily driven by an increasing need for tailored brain disease management options, the expanding utilization of cloud-based platforms for analyzing brain health data, a heightened emphasis on remote patient monitoring and telehealth services, the growing presence of smartphones and mobile applications within healthcare, and the wider acceptance of digital therapeutics for cognitive conditions. Key developments anticipated in this period encompass the incorporation of wearable brain monitoring technologies, enhancements in neurostimulation devices, the creation of closed-loop neurostimulation systems, improvements in imaging technologies, and advancements in neuroimaging methodologies.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp

Which Factors And Drivers Are Influencing The Brain Disease Device And Software Market In 2025?

The rising occurrence of neurological conditions is anticipated to drive the expansion of the brain disease device and software market. These disorders are health issues impacting the brain, spinal cord, and nerves, resulting in various symptoms like cognitive, motor, and sensory difficulties. The growing incidence of neurological disorders is connected to the world’s aging populace, given that aging progressively hinders neuronal activity, diminishes brain plasticity, and heightens oxidative stress, all of which fuel the emergence and advancement of these conditions. Tools and programs for brain diseases aid in managing neurological disorders through facilitating early detection and constant oversight. They assist in prompt intervention by utilizing advanced AI and data analytics, thereby enhancing patient care and the effectiveness of treatments. For example, data from July 2024, released by the UK-based government agency National Health Service, indicated 487,432 patients had been diagnosed with dementia (a progressive brain disorder affecting memory, thinking, and daily activities) by June 30, 2024, which marked an increase of 3,155 cases from May 31, 2024. Consequently, the expanding occurrence of neurological disorders is propelling the growth of the brain disease device and software market.

What Are The Segment Types Shaping The Brain Disease Device And Software Market?

The brain disease device and software market covered in this report is segmented

1) By Type: Brain Disease Device, Brain Disease Software

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories

Subsegments:

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software

Which Ongoing Trends Are Expected To Shape The Brain Disease Device And Software Market Outlook?

Major companies operating in the brain disease device and software market are concentrating on developing novel solutions, such as digital healthcare platforms, to improve early diagnosis and enhance the management of neurological disorders. Digital healthcare solutions refer to technology-driven tools and systems that employ software, connected devices, and data analytics to support the prevention, diagnosis, monitoring, and treatment of various health conditions, including neurological disorders. For instance, in July 2022, Linus Health Inc., a US-based digital health company, launched an iPad-based brain health platform aimed at enabling the early detection of Alzheimer’s disease and other dementias in primary care settings. This platform incorporates digital cognitive assessments and AI-driven analytics to furnish clinicians with actionable insights, thereby facilitating earlier intervention and personalized care plans. It seeks to improve the accessibility and efficiency of identifying cognitive decline at its nascent stages by integrating seamlessly into routine primary care visits. This innovation underscores the growing emphasis on digital tools to transform neurological care, offering scalable and precise methods for detecting and managing brain health conditions.

Who Are The Core Companies Influencing The Brain Disease Device And Software Market Landscape?

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report

Which Geographies Are Emerging As Strong Markets For The Brain Disease Device And Software Industry?

North America was the largest region in the brain disease device and software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Brain Disease Device And Software Market Report:

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp

Browse Through More Reports Similar to the Global Brain Disease Device And Software Market 2025, By The Business Research Company

Industrial Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/industrial-insulation-global-market-report

Building Insulation Materials Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/building-insulation-materials-global-market-report

Technical Insulation Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only._x000D_

_x000D_

#How Large Is the Brain Disease Device And Software Market Expected to Be in 2029?#_x000D_

The market size for brain disease devices and software has experienced quick escalation in past years. Its expansion is projected to shift from $14.11 billion in 2024 to $15.59 billion in 2025, reflecting a compound annual growth rate (CAGR) of 10.5%. This growth in the past has been driven by factors such as rising incidence of neurological disorders, heightened sensitivity towards initial brain disease diagnosis and treatment, escalating demand for non-invasive diagnostic instruments, increased governmental financial contributions towards healthcare establishments, and a growing tendency amongst patients to prefer home-based neurological oversight._x000D_

_x000D_

Anticipated to see significant expansion in the forthcoming years, the brain disease device and software market is projected to burgeon to a hefty $22.94 billion by 2029, flourishing at a compound annual growth rate (CAGR) of 10.1%. The growth throughout this forecast period is largely due to an increase in demand for personalized treatments for brain disorders, coupled with a rise in the utilization of cloud-based platforms for the analysis of brain health data. Also contributing to the growth are an enhanced focus on remote patient monitoring and telehealth services, the widespread use of smartphones and mobile applications in the healthcare sector, and an increasing acceptance of digital therapeutics for cognitive disorders. Looking ahead, the key trends during this period are likely to encompass the incorporation of wearable brain monitoring devices, advancements in the neurostimulation devices sector, the development of closed-loop neurostimulation systems and innovation in imaging and neuroimaging technologies._x000D_

_x000D_

#Download The Free Sample Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=27230&type=smp_x000D_

_x000D_

#What Are The Contributors To Demand In The Brain Disease Device And Software Market?#_x000D_

The growth of the brain disease device and software market is expected to be driven by the escalating incidence of neurological disorders. These are medical ailments affecting the brain, spinal cord, and nerves, resulting in a variety of symptoms such as cognitive, motor, and sensory issues. The rise in such disorders can be attributed to the aging worldwide population, which gradually leads to a decrease in neuronal function, a reduction in brain plasticity, and an increase in oxidative stress. These factors collectively contribute to the evolution and progression of these conditions. Brain disease devices and software aid in managing neurological disorders through early diagnosis and regular monitoring. They facilitate swift interventions using advanced AI and data analysis, thereby enhancing patient care and treatment outcomes. For example, as per the National Health Service, a government agency based in the UK, the number of patients diagnosed with dementia (a progressive brain disorder impacting memory, thinking, and day-to-day activities) increased by 3,155 cases to 487,432 patients by June 30, 2024 compared to May 31, 2024. Thus, the escalating incidence of neurological disorders is fueling the growth of the brain disease device and software market._x000D_

_x000D_

#What Segmentation Categories Are Included In The Brain Disease Device And Software Market Analysis?#_x000D_

The brain disease device and software market covered in this report is segmented_x000D_

_x000D_

1) By Type: Brain Disease Device, Brain Disease Software_x000D_

2) By Technology: Wearable Technology, Telemedicine Solutions, Artificial Intelligence And Machine Learning, Mobile Health Applications, Neuroimaging Technologies_x000D_

3) By Application: Alzheimer’s Disease, Parkinson’s Disease, Epilepsy, Other Applications_x000D_

4) By End-User: Hospitals And Clinics, Home Care Settings, Rehabilitation Centers, Research and Academic Institutions, Diagnostic Laboratories_x000D_

_x000D_

Subsegments:_x000D_

1) By Brain Disease Device: Neurostimulation Devices, Brain Imaging Devices, Brain Monitoring Devices, Brain-Computer Interface Devices, Neurorehabilitation Devices_x000D_

2) By Brain Disease Software: Brain Imaging Analysis Software, Cognitive Assessment Software, Neurofeedback Software, Brain Data Management Software, Neurological Disorder Diagnostic Software_x000D_

_x000D_

#What Upcoming Trends Are Expected To Impact The Brain Disease Device And Software Market Globally?#_x000D_

Key businesses in the brain disease device and software market are concentrating on the development of innovative strategies such as digital healthcare remedies to better diagnose and manage neurological conditions early. These digital healthcare solutions encompass technology-powered instruments and platforms that employ software, connected gadgets, and data analysis to aid health condition prevention, diagnosis, monitoring, and treatment, including neurological disorders. In July 2022, for example, Linus Health Inc., an American digital health firm, introduced an iPad-enabled brain health platform. This setup aims at facilitating early detection of Alzheimer’s disease and other types of dementia in fundamental healthcare environments. The platform utilizes digital cognitive evaluations and AI-propelled analysis to offer clinicians useful data, thus permitting earlier interventions and customized care programs. It seeks to enhance the accessibility and effectiveness of identifying cognitive reduction in its earliest steps by flawlessly incorporating into routine primary healthcare appointments. This innovation highlights the surge in dependence on digital tools to revolutionize neurological healthcare, providing scalable and accurate approaches to detect and handle brain health concerns._x000D_

_x000D_

#Who Are The Top-Ranked Companies In The Brain Disease Device And Software Market Today?#_x000D_

Major companies operating in the brain disease device and software market are Medtronic plc, Insightec Ltd., Cadwell Industries Inc., NeuroPace Inc., Synchron Inc., Compumedics Ltd., Neuronetics Inc., BrainsWay Ltd., The Magstim Company Ltd., Paradromics Inc., Linus Health Inc., MagVenture A/S, Neurophet Inc., Neuroelectrics Corporation, BrainScope Company Inc, Blackrock Neurotech LLC, Neurable Inc., NeuroSigma Inc., Cognixion Inc., Brightmind.AI. _x000D_

_x000D_

#Get The Full Report Here:#_x000D_

https://www.thebusinessresearchcompany.com/report/brain-disease-device-and-software-global-market-report_x000D_

_x000D_

#How Is Brain Disease Device And Software Market Adoption Varying Across Different Regions And Sectors?#_x000D_

North America was the largest region in the brain disease device and software market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain disease device and software market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#Request For A Customized Report:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=27230&type=smp_x000D_

_x000D_

#About The Business Research Company:#_x000D_

_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 310-496-7795_x000D_

Asia +44 7882 955267 & +91 8897263534_x000D_

Europe +44 7882 955267_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model